PF-07940369

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-07940369, covering 2025-08-28 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults. [Phase 1]

See pricing